Your browser doesn't support javascript.
loading
EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients.
Jittla, P; Graham, D M; Zhou, C; Halliwell, J; O'Reilly, S; Aruketty, S; Azizi, A; Germetaki, T; Lowe, J; Little, M; Punnett, G; McMahon, P; Benson, L; Carter, L; Krebs, M G; Thistlethwaite, F C; Darlington, E; Yorke, J; Cook, N.
Afiliación
  • Jittla P; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Graham DM; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Zhou C; CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.
  • Halliwell J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • O'Reilly S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Aruketty S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Azizi A; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Germetaki T; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Lowe J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Little M; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Punnett G; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.
  • McMahon P; Medical Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
  • Benson L; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Carter L; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Krebs MG; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Thistlethwaite FC; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Darlington E; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
  • Yorke J; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.
  • Cook N; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: natalie.cook17@nhs.net.
ESMO Open ; 7(5): 100550, 2022 10.
Article en En | MEDLINE | ID: mdl-35994790
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Depresión / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Depresión / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido